WHO's 'Vaccine Explained' series features illustrated articles on vaccine development and distribution. Learn more about vaccines from the earliest of research stages to their rollout in countries.
The COVID-19 vaccine introduction toolbox equips all countries to prepare for and implement COVID-19 vaccination by providing guidance, tools, and training. This toolbox is intended to support Ministries of Health, health workers, partner organizations, and other stakeholders.
The Vaccination Demand Hub is a network of partner organizations innovating together to understand why people miss out, to improve acceptance and uptake of vaccines, and to ensure that everyone everywhere is protected against vaccine preventable diseases.
This blog explains that health professionals need to approach their patients who are opposed to vaccination with understanding and patience.
Trust is fundamental to the effectiveness of public health programs, including immunization, as it is associated with program adherence. Adherence, in turn, is essential for improving critical public health outcomes.
This website, ipc.unicef.org, is part of a global package of tools and resources designed to support FLWs in their immunization work, with a focus on improving their capacity to effectively use IPC to address barriers to immunization uptake and completion.
The SAGE Working Group on Vaccine Hesitancy developed a vaccine hesitancy measure, the Vaccine Hesitancy Scale (VHS). This scale has the potential to aid in the advancement of research and immunization policy but has not yet been psychometrically evaluated.
This article deals with potential issues surrounding the COVID-19 vaccine in low and middle income countries.
This study compares Australian government vaccination campaigns from two very different time periods, the early nineteenth century (1803–24) and the early twenty-first (2016).
This document describes the principles to consider when deliberating the implementation of mass vaccination campaigns for prevention of vaccine-preventable diseases and high impact diseases (VPD/HID), and when assessing risks and benefits of conducting outbreak-response vaccination campaigns to respond to VPD/HID outbreaks.